R
Richard D. Adams
Researcher at University of South Carolina
Publications - 688
Citations - 12489
Richard D. Adams is an academic researcher from University of South Carolina. The author has contributed to research in topics: Ligand & Crystal structure. The author has an hindex of 45, co-authored 665 publications receiving 12134 citations. Previous affiliations of Richard D. Adams include University at Buffalo & Texas A&M University.
Papers
More filters
Journal ArticleDOI
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
Som D. Mukherjee,Chris Nicholas Hurt,Richard D. Adams,Andrew Bateman,Kevin M. Bradley,Sarah Bridges,Stephen Falk,Gareth Griffiths,Sarah Gwynne,Tim Maughan,Lisette Sheena Nixon,Ganesh Radhakrishna,Rajarshi Roy,Simon Schoenbuchner,Hamid Y Sheikh,Emiliano Spezi,Maria A. Hawkins,Tom Crosby +17 more
TL;DR: The role of early metabolic response assessment to guide selection of the systemic component of definitive chemoradiotherapy (dCRT) for oesophageal cancer is uncertain this paper , however, it is not prognostic for TFFS or overall survival.
Journal ArticleDOI
Importance of trinuclear coordination in the activation and desulfurization of a thioformamido ligand by a triosmium cluster
Richard D. Adams,Zain Dawoodi +1 more
Journal ArticleDOI
337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials
Sylvana Hassanieh,Enric Domingo,Andrew Blake,David E. Fisher,Keara Redmond,Susan D. Richman,Steven Walker,Philip Quirke,Richard H. Wilson,R Kennedy,Ian Tomlinson,Raina S. Kaplan,L. brown,Philip D Dunne,M. Seymour,D Morton,Richard D. Adams,Nicholas P. West,Tim Maughan +18 more
TL;DR: In this article , a biomarker of early progression on oxaliplatin based chemotherapy with potential use in the clinic to guide therapy selection was discovered, but no predictive biomarker has ever been fully validated despite intensive research.
Journal ArticleDOI
Cluster synthesis. 6. the unusual structures, bonding, and reactivity of some sulfido-bridged tungsten-osmium carbonyl cluster compounds
TL;DR: In this paper, the authors composes Os 3 W(CO) 12 (PMe 2 Ph) 2 (μ 3 -S) 2, OsW(CO), PMe 2 P(M 2 Ph 2 (M 3 S) 2, and Os W 2 (CO) 14 (PME 2 Ph(M 4 -S), OsW 2 (W 2 ) 2,